| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/1999 | EP0906109A1 Aqueous laxative syrup comprising lactulose and lactitol and/or maltitol |
| 04/07/1999 | EP0906108A1 Method of treating heart failure with endothelin antagonists |
| 04/07/1999 | EP0906107A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 04/07/1999 | EP0906106A1 Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) |
| 04/07/1999 | EP0906105A1 Improvement of implantation rates after in vitro fertilization |
| 04/07/1999 | EP0906104A1 Method for treating pain |
| 04/07/1999 | EP0906103A1 Vitronectin receptor antagonists |
| 04/07/1999 | EP0906102A1 A process for regulating vagal tone |
| 04/07/1999 | EP0906100A1 Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence |
| 04/07/1999 | EP0906099A1 A method of treating cancer |
| 04/07/1999 | EP0906098A1 Virginiamycin mixture |
| 04/07/1999 | EP0906097A1 Anti-viral compounds |
| 04/07/1999 | EP0906096A1 Agent for inhibiting leukocyte invasion of tissues |
| 04/07/1999 | EP0906095A1 7-o-methoxymethyl paclitaxel |
| 04/07/1999 | EP0906094A1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 04/07/1999 | EP0906093A1 ALPHA BLOCKERS (e.g. MOXISYLYTE AND/OR DERIVATIVES THEREOF) FOR TREATING ERECTILE DYSFUNCTION |
| 04/07/1999 | EP0906092A1 Pharmaceutical compositions based on diclofenac |
| 04/07/1999 | EP0906091A1 Amidinohydrazones as protease inhibitors |
| 04/07/1999 | EP0906090A1 Method for preventing and treating peripheral neurophathy by administering selegiline |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0906088A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 04/07/1999 | EP0906086A1 Composition |
| 04/07/1999 | EP0906078A1 Use of tempol in the prevention of photoaging |
| 04/07/1999 | EP0906019A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 04/07/1999 | EP0906015A1 Liver retention clearing agents |
| 04/07/1999 | EP0877026A4 Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 04/07/1999 | EP0868182A4 Process for production of piperidine derivatives |
| 04/07/1999 | EP0857065B1 Use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for prophylaxis and treatment of sequelae of acute and chronic reduced circulation in the brain and neurodegenerative disorders |
| 04/07/1999 | EP0854716A4 Androgenic directed compositions |
| 04/07/1999 | EP0810855A4 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 04/07/1999 | EP0799233B1 Diclavulanic acid salts with diamino ethers and process for their preparation |
| 04/07/1999 | EP0781268B1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 04/07/1999 | EP0770059B1 Substituted benzamidines, their production and their use as medicaments |
| 04/07/1999 | EP0764020B1 Transdermal drug delivery system |
| 04/07/1999 | EP0742715B1 Oral liquid compositions containing paroxetine resinate |
| 04/07/1999 | EP0738261B1 Pharmaceutical formulations comprising polythiourea and method of use thereof |
| 04/07/1999 | EP0717737B1 Chelants as contrast enhancing agents |
| 04/07/1999 | EP0705264B1 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 04/07/1999 | EP0689447B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/07/1999 | EP0688214B1 Methods for inhibiting bone loss with 3,4-diarylchroman |
| 04/07/1999 | EP0683776B1 Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria |
| 04/07/1999 | EP0681474B1 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
| 04/07/1999 | EP0669824B1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| 04/07/1999 | EP0659181B1 Sulfonamide inhibitors of hiv-aspartyl protease |
| 04/07/1999 | EP0632033B1 Novel benzopyran derivative |
| 04/07/1999 | EP0620821B1 Antiviral compositions and method for their use |
| 04/07/1999 | EP0607374B1 Novel cyclic lipid derivatives as potent paf antagonists |
| 04/07/1999 | EP0570454B1 Novel steroids |
| 04/07/1999 | EP0538313B1 Topical ophthalmic suspensions |
| 04/07/1999 | EP0481994B1 Metallo-organic cobalt compounds and uses thereof |
| 04/07/1999 | CN1213406A Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylasse deficient cells |
| 04/07/1999 | CN1213402A Recombinant expression of S-layer proteins |
| 04/07/1999 | CN1213380A Peptide immunogens for vaccination against and treatment of allergy |
| 04/07/1999 | CN1213379A Peptide derivatives |
| 04/07/1999 | CN1213372A Heterocycle-condensed morphinoid derivatives (II) |
| 04/07/1999 | CN1213370A Substituted sulfonic acid N-[(aminoiminomethyl) phenylalkyl]-azaheterocyclamide compounds |
| 04/07/1999 | CN1213369A Quinoxalinediones |
| 04/07/1999 | CN1213368A Hydroxamic acid based collagenase inhibitors |
| 04/07/1999 | CN1213364A Cinnamylidene camphor derivatives and their use as UV-A protecting agents |
| 04/07/1999 | CN1213316A Polymeric delivery of radionuclides and radiopharmaceuticals |
| 04/07/1999 | CN1213314A Improved vision through photodynamic therapy of eye |
| 04/07/1999 | CN1213313A Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 04/07/1999 | CN1213312A Anticogulant agent useful in treatment of thrombosis |
| 04/07/1999 | CN1213311A Method of using emu oil and active peactions thereof as insect repellant |
| 04/07/1999 | CN1213310A Product of heat treatment of uronic acid, food, drink or drug including the product |
| 04/07/1999 | CN1213309A Control of healing process |
| 04/07/1999 | CN1213308A Method for treating mental drug abuse |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213305A Novel cycloalkyl substituted imidazolium compounds |
| 04/07/1999 | CN1213304A Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives ad NMDA receptor subtype blockers |
| 04/07/1999 | CN1213303A Method of increasing sphincter competence |
| 04/07/1999 | CN1213302A Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
| 04/07/1999 | CN1213301A Sustained-release metal valproate tablets |
| 04/07/1999 | CN1213300A Method for preventing and treating peripheral neurophathy by administering selegiline |
| 04/07/1999 | CN1213298A 附聚物 Agglomerates |
| 04/07/1999 | CN1213297A Compositions for treating hair or skin |
| 04/07/1999 | CN1212966A Usage of steroi saponin for preventing and curing senile dementia and new steroid saponin |
| 04/07/1999 | CN1212964A Sulfonic acid amide substituted benzodihydropyrane processes for their preparation, their use as medicament and pharmaceutical preparations comprising them |
| 04/07/1999 | CN1212893A Bioactivity compound bone material and preparation method thereof |
| 04/07/1999 | CN1212890A Compositions useful for transferring therapeutically active substances into target cell, and their use in gene therapy |
| 04/07/1999 | CN1212878A Moxibustion liquid --moxibustion fixing paste and its preparation method and use method |
| 04/07/1999 | CN1212874A 'Futekang' traditional Chinese medicine emulsion and preparation method thereof |
| 04/07/1999 | CN1212869A Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/07/1999 | CN1212868A Disinfectant liquid for skin |
| 04/07/1999 | CN1212867A Composition for prevention and treatment of cardio-cerebralvascular disease |
| 04/07/1999 | CN1042795C Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds |
| 04/07/1999 | CN1042794C Improved emulsions of highly fluorinated organic compounds |
| 04/07/1999 | CA2249715A1 Abc transporter |
| 04/06/1999 | US5892114 Hetero-linked phenylglycinolamides |
| 04/06/1999 | US5892113 Protease inhibitors |
| 04/06/1999 | US5892112 Acylation of amino acids with anhydrides or carboxy groups, amidation with amine and conversion of acid or ester to hydroxamic acid and hydrolysis |
| 04/06/1999 | US5892099 Autoimmune disease, bone disorders, liver damage, cardiovascular disorders |
| 04/06/1999 | US5892098 Inhibit activity of phosphodiesterase iv and production of tumor necrosis factor; treating asthma |
| 04/06/1999 | US5892074 Synthesis of conjugated linoleic acid (CLA) |
| 04/06/1999 | US5892069 Estrogenic compounds as anti-mitotic agents |
| 04/06/1999 | US5892063 Cephalomannine epoxide, its analogues and a method for preparing the same |
| 04/06/1999 | US5892052 Process for making retroviral protease inhibiting compounds |
| 04/06/1999 | US5892045 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 04/06/1999 | US5892040 Process for the manufacture of a tricyclic compound |